Product information and disease descriptionProduct descriptionProduct information
Dosing and administration
2 evidence topics · 2 sources
Tinlarebant (LBS-008)
Stargardt disease type 1
- Manufacturer
- Belite Bio
- Regulatory submission
- NDA submitted June 2026
- Last updated